When breast cancer cells were treated with separate inhibitors for both the PI3K and MEK pathways, silencing of Ran resulted in a greater degree of apoptosis than under normal conditions, suggesting that the abnormal activation of these pathways leads to tumor cell dependence on Ran [6,118,119]. This evidence concerns the gene PIK3CG and breast cancer.